Skip to main content
Clinical Trials/CTRI/2021/04/032537
CTRI/2021/04/032537
Recruiting
未知

Comparison of Bolus Versus Continuous Infusion of Terlipressin Cirrhotic Patients With Septic Shock: A Randomized Controlled Trial

Institute of Liver and Biliary Sciences0 sites0 target enrollmentTBD

Overview

Phase
未知
Intervention
Not specified
Conditions
Health Condition 1: K746- Other and unspecified cirrhosis ofliver
Sponsor
Institute of Liver and Biliary Sciences
Status
Recruiting
Last Updated
4 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
4 years ago
Study Type
Interventional

Investigators

Eligibility Criteria

Inclusion Criteria

  • 1\) Cirrhotics with septic shock requiring norepinephrine dose \>0\.5ug/kg/min to maintain MAP \> 65 mm Hg
  • 2\) An informed consent from the patient or relative

Exclusion Criteria

  • 1\.Patients with age less than 18 years or more than 65 years
  • 2\.Severe known cardiopulmonary disease (Hypertension, structural or valvular heart disease, coronary artery disease, arrhythmias)
  • 4\.Peripheral Vascular disease
  • 5\.Gut Paralysis
  • 6\.Intestinal obstruction
  • 7\.Acute on chronic liver failure (ACLF )
  • 8\.Cancer, hepato\-cellular carcinoma (HCC), intrahepatic or extrahepatic malignancy
  • 9\.Portal vein thrombosis
  • 10\.Hepatic vein outflow tract obstruction (HVOTO )
  • 11\.Pregnancy

Outcomes

Primary Outcomes

Not specified

Similar Trials